Nelly Viseux

Nelly Viseux has extensive experience in the biotechnology and pharmaceutical industry. Nelly currently serves as the Senior Vice President of Process and Analytical Development and Clinical Manufacturing at 2seventy bio since 2022. Prior to this role, they worked as the VP of Process and Analytical Development at PlateletBio from 2021 to 2022. Nelly also held positions at MediSix Therapeutics, where they served as VP of Development Operations in 2021 and as a Sr. Director of Program Management from 2020 to 2021. Nelly worked as a Biotechnology Drug Development Consultant from 2019 to 2020 and was the VP of Technical Operations and CMC at a Stealth Cell Therapy Start-up Initiative in 2019. Nelly's prior experience includes leadership roles at Selecta Biosciences, Shire, Baxter Healthcare, and Biogen, where they specialized in pharmaceutical development, analytical development, and quality control.

Nelly Viseux holds a Ph.D. in Health and Life Sciences with a specialization in Biochemistry and Molecular Biology from the University of Lille 1 Sciences and Technology. In addition, they have obtained a Regulatory Affairs Certificate in Pharmaceuticals from the Regulatory Affairs Certification Program in June 2016. Nelly is also a member of RAPS (Regulatory Affairs Certification Program) since October 2015.